BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38082853)

  • 1. QDs-based fluorescent lateral flow assays for Point-of-care testing of insulin.
    Kaur J; Deng F; Morris MJ; Goldys E
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateral flow assay with near-infrared dye for multiplex detection.
    Swanson C; D'Andrea A
    Clin Chem; 2013 Apr; 59(4):641-8. PubMed ID: 23364182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral flow assay ruler for quantitative and rapid point-of-care testing.
    Li Z; Chen H; Wang P
    Analyst; 2019 May; 144(10):3314-3322. PubMed ID: 30968883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis.
    Wang T; Chen L; Chikkanna A; Chen S; Brusius I; Sbuh N; Veedu RN
    Theranostics; 2021; 11(11):5174-5196. PubMed ID: 33859741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A portable and universal upconversion nanoparticle-based lateral flow assay platform for point-of-care testing.
    Gong Y; Zheng Y; Jin B; You M; Wang J; Li X; Lin M; Xu F; Li F
    Talanta; 2019 Aug; 201():126-133. PubMed ID: 31122402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of Gold Nanoparticle Vertical Flow Assays for Point-of-Care Testing.
    Lei R; Wang D; Arain H; Mohan C
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lateral flow assays (LFA) for detection of pathogenic bacteria: A small point-of-care platform for diagnosis of human infectious diseases.
    Sohrabi H; Majidi MR; Fakhraei M; Jahanban-Esfahlan A; Hejazi M; Oroojalian F; Baradaran B; Tohidast M; Guardia M; Mokhtarzadeh A
    Talanta; 2022 Jun; 243():123330. PubMed ID: 35272153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated, Universal, and Mass-Producible Paper-Based Lateral Flow Biosensing Platform for High-Performance Point-of-Care Testing.
    Han GR; Ki H; Kim MG
    ACS Appl Mater Interfaces; 2020 Jan; 12(1):1885-1894. PubMed ID: 31813220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateral flow assays for detection of disease biomarkers.
    Gumus E; Bingol H; Zor E
    J Pharm Biomed Anal; 2023 Feb; 225():115206. PubMed ID: 36586382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasensitive and Highly Specific Lateral Flow Assays for Point-of-Care Diagnosis.
    Liu Y; Zhan L; Qin Z; Sackrison J; Bischof JC
    ACS Nano; 2021 Mar; 15(3):3593-3611. PubMed ID: 33607867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated lateral flow assay for effective DNA amplification and detection at the point of care.
    Choi JR; Hu J; Gong Y; Feng S; Wan Abas WA; Pingguan-Murphy B; Xu F
    Analyst; 2016 May; 141(10):2930-9. PubMed ID: 27010033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview for the Nanoparticles-Based Quantitative Lateral Flow Assay.
    Wang Z; Zhao J; Xu X; Guo L; Xu L; Sun M; Hu S; Kuang H; Xu C; Li A
    Small Methods; 2022 Jan; 6(1):e2101143. PubMed ID: 35041285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateral flow assays for hormone detection.
    Khelifa L; Hu Y; Jiang N; Yetisen AK
    Lab Chip; 2022 Jun; 22(13):2451-2475. PubMed ID: 35713489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis in European Hospitals: A Survey from Belgium and a Literature Review of Test Performances in Different Patient Populations.
    Aerts R; Cuypers L; Mercier T; Maertens J; Lagrou K
    Mycopathologia; 2023 Oct; 188(5):655-665. PubMed ID: 37209228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-based lateral flow assay on-site biosensors.
    Huang L; Tian S; Zhao W; Liu K; Ma X; Guo J
    Biosens Bioelectron; 2021 Aug; 186():113279. PubMed ID: 33979718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-Care Monitoring of Respiratory Diseases Using Lateral Flow Assay and CMOS Camera Reader.
    Raj S; McCafferty D; Lubrasky G; Johnston S; Skillen KL; McLaughlin J
    IEEE J Transl Eng Health Med; 2022; 10():2800208. PubMed ID: 35992371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents.
    Grant BD; Anderson CE; Williford JR; Alonzo LF; Glukhova VA; Boyle DS; Weigl BH; Nichols KP
    Anal Chem; 2020 Aug; 92(16):11305-11309. PubMed ID: 32605363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of aptamers as molecular recognition elements in lateral flow assays.
    Reid R; Chatterjee B; Das SJ; Ghosh S; Sharma TK
    Anal Biochem; 2020 Mar; 593():113574. PubMed ID: 31911046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Method for Blood NT-proBNP Determination Based on a Near-infrared Point of Care Testing Device with High Sensitivity and Wide Scope.
    Zhang XG; Shu YG; Gao J; Wang X; Liu LP; Wang M; Cao YX; Zeng Y
    Biomed Environ Sci; 2017 Jun; 30(6):426-431. PubMed ID: 28705266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on advances in methods for modification of paper supports for use in point-of-care testing.
    Tang RH; Liu LN; Zhang SF; He XC; Li XJ; Xu F; Ni YH; Li F
    Mikrochim Acta; 2019 Jul; 186(8):521. PubMed ID: 31289938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.